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Angiomyolipoma is a common benign renal tumor. It is typically composed of adipose tissue and hence is easily
diagnosed by using imaging methods such as ultrasonography, computed tomography, and magnetic resonance
imaging. However, it is difficult to differentiate an atypical angiomyolipoma such as a fat-poor angiomyolipoma
from a malignant tumor by using these imaging methods. We report a case of a fat-poor angiomyolipoma with
cyst-like changes in a 35-year-old man. The angiomyolipoma was initially suspected to be a cystic renal cell carcinoma
according to preoperative imaging studies. A 5-cm cystic tumor with an enhanced septal wall and exophytic formation
was present in the middle section of the left kidney. The patient underwent partial nephrectomy. Pathological findings
showed necrosis and hematoma in almost the entire lesion, with a small amount of adipose and muscle tissue. Finally,
a fat-poor angiomyolipoma was diagnosed.
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Angiomyolipoma (AML) is one of the most common be-
nign solid triphasic renal tumors and is composed of
varying amounts of dysmorphic blood vessels, smooth
muscles, and mature adipose tissue [1, 2]. As most
AMLs contain substantial amounts of adipose tissue, it
is usually diagnosed by using computed tomography
(CT) or magnetic resonance imaging (MRI), both of
which identify the characteristic imaging features of fat
cells in the mass. AMLs that can be diagnosed on im-
aging are called “classic” AMLs. On the other hand, dif-
ferent types of AML, which include a heterogeneous
group of neoplasms with variable clinical behavior, radi-
ology, and pathology, also exist. In particular, some tri-
phasic AMLs contain very few fat cells, which cannot be
detected on imaging. These are called fat-poor AMLs
and are sometimes mistaken for renal cancers [3–6]. As
already mentioned, the cystic renal mass contains few or
no fat cells, and it is categorized as a type of fat-poor* Correspondence: t.takagi1192@gmail.com
1Department of Urology, Tokyo Women’s Medical University, 8-1,
Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan
Full list of author information is available at the end of the article
© 2015 Kobari et al. Open Access This article
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zeAML known as an AML with epithelial cysts. Although
AML is a benign tumor, a few cases of epithelioid AML
develop malignant clinical courses [7, 8]. Herein, we re-
port a case of a fat-poor AML with cyst-like changes.Case presentation
A 35-year-old-Japanese man was referred to our depart-
ment because of left back pain. He did not have any rele-
vant medical or family history.
Ultrasonography showed a low-echoic cystic lesion in
the left kidney. CT revealed a 5-cm cystic renal mass with
a mixed compartment consisting of a mainly hypodense
area with a partially hyperdense area in the middle pole of
the left kidney. The hyperdense area and septa were en-
hanced in the early phase and washed out in the late phase
(Fig. 1). On T2-weighted MRI, the cystic mass and septal
wall appeared as hyperintense and hypointense areas, re-
spectively. Moreover, the continuity between the renal
parenchyma and the cystic mass was not clear. T1-
weighted MRI showed no signal change between the in-
phase and out-of-phase images, indicating that this cystic
mass had no adipose tissue (Fig. 2). Finally, the patientis distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Fig. 1 Preoperative computed tomography. The renal mass appears mainly as a hypodense area (a) with a partially hyperdense area (d) on
unenhanced computed tomography. The hyperdense area and septa are enhanced in the early phase (b, e) and washed out in the late phase
(c, f). White arrows show the area where CT attenuation value is calculated
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cinoma (Bosniak category IV) or a retroperitoneal tumor.
The patient underwent partial nephrectomy. The
tumor peeled away easily from the renal surface and ad-
hered to the renal capsule with a very small area, sug-
gesting that the tumor had originated in the kidney. The
size of the surgical specimen was 4.0 × 4.0 × 2.5 cm, and
macroscopic findings showed dark reddish spongiform
contents rounded with capsule (Fig. 3a). Pathologically,
the tumor showed predominance. Notably, the septa did
not contain adipose tissue and smooth muscle-like spin-
dle cells (Fig. 3b). Immunohistochemically, the spindle
cells were positive for melanosome-associated antigen
detected by the human melanoma black-45 antibodyFig. 2 Preoperative magnetic resonance imaging (MRI). On T2-weighted MRI
areas, respectively. Moreover, the continuity between the renal parenchyma a
does not show a signal change between the in-phase (c, f) and out-of-phase(Fig. 3c), smooth muscle actin, and S-100 protein, but
negative for cytokeratin (AE1/AE3; Fig. 3d). The Ki-67
labeling index was less than 5 %. Accordingly, the tumor
was diagnosed as a fat-poor AML causing a cystic
change due to intratumoral hemorrhage.
Discussion
Renal AML is a solid tumor that is encountered com-
monly in clinical practice [2]. AML is typically a solid tri-
phasic tumor composed of varying amounts of the
following three elements: dysmorphic blood vessels,
smooth muscle, and mature adipose tissue. AMLs belong
to the perivascular epithelioid cell tumor family in the
2002 World Health Organization classification [9, 10]., the cystic mass and septal wall appear as hyperintense and hypointense
nd the cystic mass is not clear (a, d – black arrows). T1-weighted MRI
(b, e) images, indicating that the cystic mass has no adipose tissue
Fig. 3 Pathological findings of the resected tumor. Grossly, the tumor was continuous with the renal capsule and adherent with the perirenal fat. The
border is well demarcated. The cut surface is dark red with hemorrhage (a). Histologically, the tumor is mostly hemorrhagic with a less amount of
spindle cells and fat in the septa (hematoxylin and eosin, original magnification ×100) (b). Immunohistochemically, the spindle-shaped cells are reactive
with the human melanoma black-45 antibody, demonstrating the melanosome-associated antigen, (c) but negative for cytokeratin (antibody clone
AE1/AE3). The cyst wall lacks epithelial lining, unlike angiomyolipoma with epithelial cyst (d)
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findings on medical examinations, but symptoms such as
hematuria, pain, and mass palpation and signs such as
retroperitoneal bleeding often occur when the tumor size
is more than 4 cm [11–13]. AML is comparatively easy to
diagnose through fat detection by using CT or MRI [2].
However, recent research has shown that some AMLs
contain too little fat to be detected on unenhanced CT
[14, 15] and that it is hard to distinguish some AMLs with
cystic lesions from renal cell carcinoma because of intra-
tumoral bleeding [16]. In the present case, it was difficult
to diagnose AML because of a cyst-like formation and no
fat tissue on preoperative imaging. Moreover, the tumor
had the potential to be malignant owing to a slightly en-
hanced septal wall within the cystic area. Therefore, the
patient underwent partial nephrectomy. The tumor was fi-
nally diagnosed as a “cyst-like change” rather than a renal
cyst, suggesting that a hemorrhagic lesion from the AML
had gradually expanded within the renal capsule and that
it might have been diagnosed as a cystic mass on pre-
operative imaging. These implications were supported by
the pathological findings of the hemorrhagic area and ab-
sence of cytokeratin in the cyst wall.
The term “AML with minimal fat” was reported for
the first time in 1997 and accounts for approximately
5 % of all AMLs [17]. Various terms have been used for
AMLs containing very little fat such as “lipid-poor
AML” or “minimal fat AML.” Jinzaki et al. defined
AMLs with no evidence of fat cells on unenhanced CTas fat-poor AMLs because of the pathology of these le-
sions, and they explained the presence of multiple sub-
types of fat-poor AMLs to reduce readers’ confusion [1].
Some reports recommend a biopsy for tumors with an
attenuation value of more than 40 Hounsfield units on
unenhanced CT, and without fat cells on MRI, to differ-
entiate AMLs from renal cell carcinoma [1, 18]. Our
case was not suitable for a tumor biopsy because of the
cyst-like formation.
We report a case of a fat-poor AML with cyst-like
changes, which was difficult to differentiate from a cystic
renal cell carcinoma by using preoperative imaging. The
etiology of this cystic change from a very tiny tumor is
relatively rare. Therefore, we present this case report.
Conclusions
We report a case of a fat-poor AML with cyst-like
changes, which was difficult to differentiate from a cystic
renal cell carcinoma by using preoperative imaging.
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